Translation of "CNS depressant drug " (English → French) :

central nervous system depressant [ CNS depressant drug ]

central nervous system depressant | CNS depressant | depressant | depressant drug

bipolar affective disorder | bipolar disorder | bipolar manic-depressive illness | bipolar mood disorder | manic depression | manic depressive psychosis | manic depressive reaction | manic-depressive illness | BAD [Abbr.] | BPAD [Abbr.] | MDI [Abbr.]

drug addiction [ drug abuse | drug-taking | fight against drugs | drug addicts(UNBIS) ]

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

central nervous system drug [ CNS drug | central nervous system agent | CNS agent ]

European Monitoring Centre for Drugs and Drug Addiction [ EMCDDA [acronym] European Monitoring Centre for Drugs ]

drug traffic [ drug trafficking | narcotics traffic | Drugs economy(STW) ]

CNS, Endocrine and Antiparasitic Drugs Division

(a) ‘new psychoactive substance’ means a natural or synthetic substance that, when consumed by a human, has the capacity to produce central nervous system stimulation or depression, resulting in hallucinations, alterations in motor function, thinking, behaviour, perception, awareness or mood, which is intended for human consumption or is likely to be consumed by humans even if not intended for them with the purpose of inducing one or more of the effects mentioned above, which is neither controlled under the 1961 United Nations Single Convention on Narcotic Drugs, as amend ...[+++]ed by the 1972 Protocol, nor the 1971 United Nations Convention on Psychotropic Substances; it excludes alcohol, caffeine and tobacco, as well as tobacco products within the meaning of Council Directive 2001/37/EC of 5 June 2001 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco products ;

Citalopram, originally developed by Lundbeck, is an anti-depressant drug known as a selective serotonin reuptake inhibitor (SSRI).

Your rapporteur believes that the prevention of depression and suicide calls for the implementation of cross-sectoral programmes which focus on promoting healthy lifestyles, reducing risk factors, such as easy access to medicines, drugs, alcohol abuse, and providing support for and monitoring people who have attempted suicide and the families of those who have committed suicide, making it clear that depression is a treatable disorder and suicide a preventable act.

- to calculate the costs of drug addiction, whether direct (treatments for drug dependence, psychotic disorders, depression, violent behaviour, high-risk conduct, accidents, HIV/Aids, hepatitis C, fertility problems, pregnancy and the transmission of certain drugs from the mother to the foetus), indirect (loss of motivation at school or work, unemployment, crime due to drug abuse), or human, with particular reference to mothers and their children,